519 related articles for article (PubMed ID: 17469202)
21. Splicing-directed therapy in a new mouse model of human accelerated aging.
Osorio FG; Navarro CL; Cadiñanos J; López-Mejía IC; Quirós PM; Bartoli C; Rivera J; Tazi J; Guzmán G; Varela I; Depetris D; de Carlos F; Cobo J; Andrés V; De Sandre-Giovannoli A; Freije JM; Lévy N; López-Otín C
Sci Transl Med; 2011 Oct; 3(106):106ra107. PubMed ID: 22030750
[TBL] [Abstract][Full Text] [Related]
22. Hutchinson-Gilford progeria syndrome.
Pollex RL; Hegele RA
Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
[TBL] [Abstract][Full Text] [Related]
23. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
Chen X; Yao H; Andrés V; Bergo MO; Kashif M
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
[TBL] [Abstract][Full Text] [Related]
24. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
25. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
26. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
Verstraeten VL; Broers JL; van Steensel MA; Zinn-Justin S; Ramaekers FC; Steijlen PM; Kamps M; Kuijpers HJ; Merckx D; Smeets HJ; Hennekam RC; Marcelis CL; van den Wijngaard A
Hum Mol Genet; 2006 Aug; 15(16):2509-22. PubMed ID: 16825282
[TBL] [Abstract][Full Text] [Related]
27. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
[TBL] [Abstract][Full Text] [Related]
28. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
Wang Y; Ostlund C; Worman HJ
Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
[TBL] [Abstract][Full Text] [Related]
29. Alteration of splice site selection in the LMNA gene and inhibition of progerin production via AMPK activation.
Finley J
Med Hypotheses; 2014 Nov; 83(5):580-7. PubMed ID: 25216752
[TBL] [Abstract][Full Text] [Related]
30. Longwave UV light induces the aging-associated progerin.
Takeuchi H; Rünger TM
J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
[TBL] [Abstract][Full Text] [Related]
31. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
[TBL] [Abstract][Full Text] [Related]
32. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
[TBL] [Abstract][Full Text] [Related]
33. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
[TBL] [Abstract][Full Text] [Related]
34. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
[TBL] [Abstract][Full Text] [Related]
35. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
Eisch V; Lu X; Gabriel D; Djabali K
Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
[TBL] [Abstract][Full Text] [Related]
36. Antisense oligonucleotide induction of progerin in human myogenic cells.
Luo YB; Mitrpant C; Adams AM; Johnsen RD; Fletcher S; Mastaglia FL; Wilton SD
PLoS One; 2014; 9(6):e98306. PubMed ID: 24892300
[TBL] [Abstract][Full Text] [Related]
37. Antisense-Based Progerin Downregulation in HGPS-Like Patients' Cells.
Harhouri K; Navarro C; Baquerre C; Da Silva N; Bartoli C; Casey F; Mawuse GK; Doubaj Y; Lévy N; De Sandre-Giovannoli A
Cells; 2016 Jul; 5(3):. PubMed ID: 27409638
[TBL] [Abstract][Full Text] [Related]
38. Embryonic expression of the common progeroid lamin A splice mutation arrests postnatal skin development.
McKenna T; Rosengardten Y; Viceconte N; Baek JH; Grochová D; Eriksson M
Aging Cell; 2014 Apr; 13(2):292-302. PubMed ID: 24305605
[TBL] [Abstract][Full Text] [Related]
39. Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.
Luo YB; Mitrpant C; Johnsen RD; Fabian VA; Fletcher S; Mastaglia FL; Wilton SD
Int J Clin Exp Pathol; 2013; 6(12):2778-86. PubMed ID: 24294364
[TBL] [Abstract][Full Text] [Related]
40. MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients' Cells.
Harhouri K; Cau P; Casey F; Guedenon KM; Doubaj Y; Van Maldergem L; Mejia-Baltodano G; Bartoli C; De Sandre-Giovannoli A; Lévy N
Cells; 2022 Feb; 11(4):. PubMed ID: 35203262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
